CoChat

Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs

The DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.

Abstract

There is a high prevalence of painful diabetic polyneuropathy (pDPN) with around one-third of all patients with diabetes suffering from pDPN. pDPN has debilitating consequences, with a major impact on morbidity and quality of life. Unfortunately, there is no globally licenced pharmacotherapy that modulates the underlying disease mechanisms to prevent or halt the progression of diabetic neuropathy. The cornerstone of treatment therefore remains optimising glycaemic control and cardiovascular risk factors, and symptom control. Evidence from placebo-controlled studies has shown that antidepressants and anticonvulsants are effective for alleviating pDPN. Current clinical guidelines recommend the treatment of pDPN through the use of amitriptyline (tricyclic antidepressant), duloxetine (serotonin norepinephrine reuptake inhibitor), gabapentin and pregabalin (α2-δ ligands), tramadol and tapentadol (μ receptor agonists and norepinephrine reuptake inhibitors) and topical agents such as capsaicin (transient receptor potential V1 receptor desensitizer), although the latter is known to cause degeneration of small nerve fibers. pDPN can be difficult to treat, which frustrates healthcare providers, patients and caregivers. There is an additional need for clinical trials of novel therapeutic agents and optimal combinations for the management of pDPN. This article reviews the pharmacological management of pDPN, emerging therapies, the difficulties of placebo response in clinical trials and n…

Overview

Integrity signals

Registry

Crossref · 10.1007/s40265-020-01259-2

Cites

248 of 248 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 248 references

Research works printed but not linked: 7

  1. IDF. IDF diabetes atlas. 8th Edition ed: Web; 2017.
  2. Sansone RA, Sansone LA. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innov Clin Neurosci. 2014;11(3–4):37–42.
  3. Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018;40(6):828–49. · DOI · Paper page
  4. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013(8). · DOI · Paper page
  5. Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J. 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review. Swiss Med Wkly. 2010;140(21–22):297–306.
  6. Basit A, Basit KA, Fawwad A, Shaheen F, Fatima N, Petropoulos IN, et al. Vitamin D for the treatment of painful diabetic neuropathy. BMJ Open Diabetes Res Care. 2016;4(1):e000148. · DOI
  7. H.J. M. Placebo and control event rate. In: McQuay H.J., editor. Systematic reviews in pain research: methodology redefined. IASP Press, Seattle; 2008. pp. 51–6.

Cited by

See all 105

Metadata

Authors
Alam, U., Sloan, G., & Tesfaye, S.
Affiliations
  • University of Liverpool (GB)
  • Royal Hallamshire Hospital (GB)
Corresponding author
Alam, Uazman
Venue
Drugs
Published
2020-02-10
Volume
80
Issue
4
Pages
363-384
ISSN
  • 0012-6667 (ISSN-L)
  • 1179-1950
OpenAlex
W3005601005
Cited by
104
References
249
Citations by year
2026: 11 · 2025: 16 · 2024: 9 · 2023: 13 · 2022: 20 · 2021: 18 · 2020: 17
FWCI
2.16
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
  • Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
Keywords
painful diabetic polyneuropathy, neuropathic pain, pharmacotherapy, antidepressants, antiepileptic drugs, amitriptyline, duloxetine, gabapentin, pregabalin, tramadol, tapentadol, capsaicin, topical agents, new drugs, placebo response, treatment response biomarkers
MeSH terms
Anticonvulsants, Antidepressive Agents, Diabetic Neuropathies, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs. https://app.cochat.ai/papers/10.1007/s40265-020-01259-2
The paper
Alam, U., Sloan, G., & Tesfaye, S. (2020). Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs. Drugs. https://doi.org/10.1007/s40265-020-01259-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.